Poland· PL-100525000

Dorin

A g03hb, g03aa16 product containing ethinylestradiolum + dienogestum, registered in Poland by Medezin Sp. z o.o..

ATC G03HB, G03AA16

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDorinATCG03HB, G03AA16REGISTER NO.PL-100525000PACKS LISTED3CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Ethinylestradiolum + Dienogestum
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
G03HB, G03AA16
ATC class
G03HB, G03AA16
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991584344
  • gtin
    05909991584351
  • gtin
    05909991584368

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ethinylestradiolum + dienogestum in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethinylestradiolum + dienogestum products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Dienorette, Dienovel
  • Belgium · Dienobel, Louise
  • Bulgaria · Жанин
  • Czechia · Aidee, Ayreen
  • Germany · Amobena, Aristelle
  • Denmark · Yana
  • Estonia · Ammily, Jeanine
  • Spain · Adieris, Ailyn Diario
  • Finland · Yanulez
  • France · Misolfa
  • United Kingdom (Northern Ireland) · Dienogest/Ethinylestradiol, Serisima
  • Croatia · Donella
  • Hungary · Dienille, Mistral
  • Ireland · Mistra, Raener
  • Italy · Cemisiana, Dienestra
  • Lithuania · Ammily, Jeanine
  • Luxembourg · Dienobel, Louise
  • Latvia · Ammily, Jeanine
  • Netherlands · Ethinylestradiol/Dienogest Mithra, Misolfa
  • Norway · Yana
  • Portugal · Denille, Dienogest + Etinilestradiol Leon Farma
  • Slovakia · Aidee, Dienorette

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df0c33da-8ce6-4a85-861b-3fa9e0bb0f68
GET /v1/drugs/df0c33da-8ce6-4a85-861b-3fa9e0bb0f68?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "0,03 mg + 2 mg",
  "packaging": "05909991584344 ¦ Rp ¦ 163742\n21 tabl.\n05909991584351 ¦ Rp ¦ 163743\n42 tabl.\n05909991584368 ¦ Rp ¦ 163744\n63 tabl.",
  "substance": "Ethinylestradiolum 0.03 mg + Dienogestum 2 mg",
  "common_name": "Ethinylestradiolum + Dienogestum",
  "pl_product_id": "100525000",
  "pozwolenie_nr": "300/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-09-10"
}

See everything about ethinylestradiolum + dienogestum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.